Clinical Trials Sponsored by JSP Innovations

Total 1728 results

Novavax
Coalition for Epidemic Preparedness Innovations

Completed

Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant

COVID-19

United States, Australia
SCRI Development Innovations, LLC
Bayer; Novartis

Completed

Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer

Kidney Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer

Esophageal Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Colorectal Cancer | Rectal Cancer | Cancer of the Rectum

United States
Vascular Innovations Co. Ltd.
MedPass International

Active, not recruiting

A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve

Aortic Valve Stenosis

New Zealand, Hong Kong, Thailand, Greece, Lithuania, Poland
SCRI Development Innovations, LLC
Novartis Pharmaceuticals

Completed

Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer

Prostate Cancer

United States
Urovant Sciences GmbH
Ion Channel Innovations

Terminated

Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity

Overactive Bladder

United States
SCRI Development Innovations, LLC
GlaxoSmithKline; Celgene

Withdrawn

Study of Trametinib and Nab-paclitaxel in Patients With Melanoma

Melanoma

United States
Urovant Sciences GmbH
Ion Channel Innovations

Completed

Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer (OAB)

Overactive Bladder

United States
Cambridge Respiratory Innovations Limited
Innovate UK

Completed

The General Breathing Record Study (GBRS)

Heart Failure | Pneumonia | Motor Neuron Disease | Asthma | Vocal Cord Dysfunction | Breathlessness

United Kingdom
Baxter Healthcare Corporation
Synovis Surgical Innovations

Terminated

Veritas in Non-Bridging Ventral Hernia Repair (VIBE)

Hernia

United States
SCRI Development Innovations, LLC
GlaxoSmithKline; Novartis

Completed

Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Completed

Retrospective Analysis of Veritas in Breast Reconstruction (RAVE)

Necrosis | Infection | Seroma

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Withdrawn

The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers

Venous Leg Ulcers

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Terminated

Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma

Primary Central Nervous System Lymphoma

United States
SCRI Development Innovations, LLC
Eisai Inc.

Completed

Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer

HER2 Negative Breast Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers

Neuroendocrine Carcinoma

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

High-dose Bevacizumab in Advanced Renal Carcinoma Patients

Kidney Cancer | Renal Cancer

United States
SCRI Development Innovations, LLC
Biotheranostics, Inc.

Completed

Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer

Unknown Primary Cancer

United States
SCRI Development Innovations, LLC
Celgene Corporation

Completed

CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas

Pancreatic Cancer

United States
SCRI Development Innovations, LLC
Aventis Pharmaceuticals

Completed

Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer

Breast Cancer
SCRI Development Innovations, LLC
Aventis Pharmaceuticals

Completed

Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer

Prostate Cancer

United States
SCRI Development Innovations, LLC
CTI BioPharma

Completed

Arsenic Trioxide in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site

Neoplasms, Unknown Primary
SCRI Development Innovations, LLC
Aventis Pharmaceuticals

Completed

Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly Patients

Lung Cancer

United States
SCRI Development Innovations, LLC
CTI BioPharma

Completed

Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma

Multiple Myeloma
SCRI Development Innovations, LLC
Genentech, Inc.

Active, not recruiting

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

Non-Small Cell Lung Cancer | Solid Tumor

United States
University of Michigan
Archimedes Innovations, Pbc

Active, not recruiting

The Effect of Violet Device Dosed Ultra Violet-C Light (UV-C) Exposure on Healthy Hand Skin

Healthy Volunteers

United States
CureVac
Coalition for Epidemic Preparedness Innovations

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Severe Acute Respiratory Syndrome | COVID-19 | SARS-CoV-2 | Coronavirus

Belgium, Germany
SCRI Development Innovations, LLC
Novartis Pharmaceuticals

Terminated

LBH589 in Refractory Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes (MDS)

United States
E25Bio, Inc.
SCRI Development Innovations, LLC

Completed

A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests

SARS CoV-2

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Terminated

The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer

Diabetic Foot Ulcers

United States
Leiden University Medical Center
Atrium Innovations

Completed

Diet and Aggression: Reducing Aggression Among Chronic Psychiatric Inpatients Through Dietary Supplementation

Psychiatric Hospitalization

Netherlands
University of Washington
Synovis Surgical Innovations

Completed

Veritas Laparoscopic Paraesophageal Hiatal Hernia (PEH) Repair Pilot Trial

Hiatal Hernia

United States
AEterna Zentaris
SCRI Development Innovations, LLC

Completed

Study of Perifosine + Capecitabine for Colon Cancer Patients

Colon Cancer
Genentech, Inc.
SCRI Development Innovations, LLC

Completed

FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Completed

Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery

Colorectal Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site

Carcinoma

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma

Lymphoma, Follicular

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site

Neoplasm, Unknown Primary

United States
Baxter Healthcare Corporation
Baxter Innovations GmbH

Completed

Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection

Bleeding (Oozing) in Hepatic Resection

Germany
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Carcinoma, Small Cell Lung

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer

Lung Cancer | Carcinoma, Small Cell Lung

United States
Sound Wave Innovation CO., LTD.

Recruiting

A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease

Alzheimer Disease, Early Onset

Japan
Hopital Montfort
AFP Innovation Fund

Completed

Endocuff Enhanced Colonoscopy: Does it Improve Polyp Detection and Make Rectal Retroflexion Unnecessary

Colorectal Cancer | Colonic Polyps

Canada
GeNeuro Innovation SAS

Terminated

A Long-term Extension of Study GNC-401

Multiple Sclerosis

Sweden
Nordsjaellands Hospital
Innovation Fund Denmark

Completed

Catheter-based Peripheral Regional Anesthesia After Orthopedic Surgery to the Foot or Ankle (API-FOOT)

Postoperative Pain

Denmark
The Orthopaedic Research & Innovation Foundation

Active, not recruiting

Proximal Humerus Fractures: A Retrospective Analysis (PHFx)

Proximal Humeral Fracture

United States
Cellceutix Corporation

Completed

Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers

Psoriasis

United States
Center for Social Innovation, Massachusetts

Completed

CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care (CSCOnDemand)

Psychosis

United States

Clinical Trials Sponsored by JSP Innovations

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations